Spirulina and Zinc Metalloproteins.

Zinc as Structural and Catalytic Cofactor

Zinc (Zn²&sup+;; d¹° Lewis acid; tetrahedral or trigonal geometry; no redox chemistry under physiological conditions; ideal for structural and Lewis acid catalysis) is the second most abundant transition metal in the body (~2–3 g total; predominantly in skeletal muscle, bone, liver, prostate, retina). Zn²&sup+; fulfils three roles: catalytic (SOD1, CA/carbonic anhydrase, MMP active sites, alcohol dehydrogenase ADH, carboxypeptidase, alkaline phosphatase; Zn coordinates substrate/water molecule for nucleophilic attack); structural (zinc finger domains of TFs: Cys2His2, Cys4, Cys3His; RING domains; LIM domains; DNA polymerase; PCNA interaction; PARP1 Zn1/2 domain zinc ribbons); co-catalytic (multiple Zn²&sup+; in lens α-crystallin, alkaline phosphatase). Labile Zn²&sup+; (chelatable pool; ~100–500 μM total tissue; free [Zn²&sup+;] ~0.1–1 nM cytoplasm; measured by FluoZin-3) is released from metallothioneins (MT) by oxidative/nitrosative stress (MT Cys-S-NO → Zn release) and acts as a signalling molecule: neuronal Zn²&sup+; (vesicular; ZnT3/SLC30A3 loads synaptic vesicles; ~100–300 μM pre-synaptic → NMDAR inhibition at Gly1b site; T-type Ca²&sup+; channel ↓).

Zinc Transporters: ZnT and ZIP Families

Zinc transport is bidirectional via two opposing families: ZnT (SLC30A; 10 members; Zn²&sup+; exporters from cytoplasm to organelles/extracellular; ZnT1 PM; ZnT2 vesicles; ZnT3 synaptic vesicles; ZnT4 trans-Golgi; ZnT5/6 Golgi; ZnT7 Golgi; ZnT8 insulin secretory granules/T2DM susceptibility Trp325Arg variant) and ZIP (SLC39A; 14 members; Zn²&sup+; importers into cytoplasm; ZIP1/3 PM import; ZIP4 duodenal dietary Zn absorption; ZIP7 ER lumen→cytoplasm; ZIP8/14 lysosomal). ZIP7 (SLC39A7) is regulated by CK2 Ser275/276 phosphorylation → ZIP7 active → Zn²&sup+; burst from ER into cytoplasm → kinase activation (EGFR, Akt, ERK) in growth signalling (“zinc spark”). MT1/MT2 (metallothioneins; 61/68 aa; 20 Cys; Cys3-cluster α-domain 4 Zn; Cys9-cluster β-domain 3 Zn; induced by Zn/Cd/Cu via MTF-1 MRE elements; Nrf2 ARE at −1.2 kb; NF-κB κB at −500 bp) buffer cytoplasmic Zn and defend against heavy metal toxicity.

SOD1 and Carbonic Anhydrase Active Sites

Cu/Zn-superoxide dismutase (SOD1; 154 aa; homodimer; 1 Cu + 1 Zn per subunit; Cu at His46/His48/His63/His120; Zn at His63/His71/His80/Asp83; disulphide bond Cys57–Cys146; Cu catalyses O&sub2;•− dismutation: Cu²&sup+; + O&sub2;•− → Cu&sup+; + O&sub2;; Cu&sup+; + O&sub2;•− + 2H&sup+; → Cu²&sup+; + H&sub2;O&sub2;; Kcat ~2×10&sup9; M−s−¹; Zn structural/electrostatic role; ALS-associated mutations G93A/D90A destabilise Zn-binding→apo-SOD1 aggregation). Carbonic anhydrases (CA; 16 isoforms; CA I/II cytoplasmic; CA IV GPI-anchored; CA IX/XII HIF-1α-induced in cancer; catalytic Zn²&sup+; at His94/His96/His119; water molecule at Zn; CO&sub2; + H&sub2;O → HCO&sub3;− + H&sup+;; Kcat ~10&sup6;–10&sup7;/s; CA II Kcat ~10&sup6;/s for CO&sub2; hydration; acetazolamide carbonate anhydrase inhibitor; sulphonamide Zn-binding). CA II activity is critical for intracellular pH buffering and bicarbonate transport; CA IX on tumour cell surfaces is a therapeutic target.

Spirulina’s Mechanistic Actions

• Zn provision and bioavailability: Spirulina ~2–5 mg Zn/100g DW; minimal phytic acid (unlike cereals; phytate→Zn chelation reduces bioavailability to ~5–15%); spirulina Zn fractional absorption estimated ~15–25% (superior to legumes; comparable to meat); supports >300 Zn metalloenzyme active sites in Zn-deficient subjects; serum Zn ↑ 10–20% after 8 weeks in deficient subjects.
• Nrf2 → MT1/MT2 ↑ (Zn buffering and heavy metal protection): Nrf2→MT1/2 ARE (HMOX1 co-regulated locus)→MT1/2 ↑ 20–35%→cytoplasmic Zn buffer ↑→free [Zn²&sup+;] homoeostasis improved; excess dietary Zn (from co-supplementation) buffered without toxicity; Cd²&sup+;/Pb²&sup+; heavy metal competition for MT→MT-Cd/Pb displaces Zn (less toxic than naked metal); spirulina phytochelatin-like peptides (proposed) may also bind heavy metals.
• SOD1 Zn/Cu status support: Spirulina Zn provision supports SOD1 Zn-binding domain (His71/His80/Asp83) stability; PCB antioxidant reduces peroxynitrite that nitrates SOD1 Tyr34 (mitochondrial SOD2) and Tyr108 (SOD1)→SOD inactivation ↓; SOD1 activity ↑ 10–20% in Zn-repleted deficient subjects.
• NF-κB Zn-finger domain function: NF-κB p50/p65 contain a Zn-coordinating motif in the RHD/DNA-binding loop; subphysiological Zn (<0.1 nM free) reduces NF-κB–DNA binding affinity; spirulina Zn supplementation restores optimal NF-κB DNA-binding in Zn-deficient immune cells (paradox: spirulina both suppresses NF-κB via PCB and maintains its structural Zn competence for normal immune function in deficiency contexts).
• ZIP7→ER Zn burst and growth signalling: AMPK modulates CK2 activity (AMPK→CK2↓ in over-nutrition contexts)→ZIP7 phosphorylation ↓→ER Zn burst ↓→EGFR/Akt/ERK Zn-spark signalling ↓ (anti-proliferative in cancer; neutral in normal cells).

Clinical Correlates and Dosing

Human data: 4–8 g/day spirulina for 8–12 weeks increases serum Zn 10–20% in deficient subjects (IDA/elderly cohorts); SOD activity ↑ 10–20% (3 RCTs); wound healing improvement consistent with adequate Zn. In Zn-sufficient subjects, serum Zn unchanged (hepcidin-like Zn homeostasis via MT/ZIP regulation prevents excess). Interactions: high-dose zinc supplements (>25 mg/day elemental) + spirulina may cause excess Zn accumulation if taken simultaneously; space doses if using therapeutic Zn. Ca/Fe supplements may reduce Zn absorption if taken together; separate by 2 hours.